Qi Zhu
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
The Therapeutic Effect and Mechanism of Vismodegib on COPD: Focusing on NETs and Macrophage Polarization.
Journal: Chemical biology & drug design
Published: August 25, 2025
Pulmonary tuberculosis complicated with bronchial lipoma: a case report and literature review.
Journal: BMC pulmonary medicine
Published: December 26, 2024
Identification of the novel markers of PPAR signalling affecting immune microenvironment and immunotherapy response of lung adenocarcinoma patients.
Journal: Journal of cellular and molecular medicine
Published: May 21, 2023
Characterization of peripheral cytokine-secreting cells responses in HIV/TB co-infection.
Journal: Frontiers in cellular and infection microbiology
Published: February 09, 2023
Phenotype and function of peripheral blood γδ T cells in HIV infection with tuberculosis.
Journal: Frontiers in cellular and infection microbiology
Published: October 17, 2022
Frequency and functional profile of circulating TCRαβ+ double negative T cells in HIV/TB co-infection.
Journal: BMC infectious diseases
Published: June 20, 2022
The Role of CD4+CD8+ T Cells in HIV Infection With Tuberculosis.
Journal: Frontiers in public health
Published: March 13, 2022
An evolvable adversarial network with gradient penalty for COVID-19 infection segmentation.
Journal: Applied soft computing
Published: May 31, 2021
Transcriptomic characteristics and impaired immune function of patients who retest positive for SARS-CoV-2 RNA.
Journal: Journal of molecular cell biology
Published: April 22, 2021
Favipiravir in the treatment of patients with SARS-CoV-2 RNA recurrent positive after discharge: A multicenter, open-label, randomized trial.
Journal: International immunopharmacology
Published: January 26, 2021
The relationship between SARS-COV-2 RNA positive duration and the risk of recurrent positive.
Journal: Infectious diseases of poverty
Published: January 13, 2021
Tocilizumab combined with favipiravir in the treatment of COVID-19: A multicenter trial in a small sample size.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 16, 2020
Last Updated: 09/26/2026